SCHEMBL21687976

SCHEMBL21687976

N#Cc1ccc(-c2cccc([Si](c3ccccc3)(c3ccccc3)c3ccccc3)c2)cc1-n1c2ccccc2c2ccccc21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
LMNA P02545 2/20 0.36
HPGD P15428 1/20 0.36
MAPK1 P28482 1/20 0.36
CYP11B1 P15538 2/20 0.36
CYP11B2 P19099 2/20 0.36
HIF1A Q16665 1/20 0.36
KDM4E B2RXH2 2/20 0.35
ATM Q13315 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
HTT P42858 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35
THRB P10828 1/20 0.35
TDP1 Q9NUW8 2/20 0.33
NPSR1 Q6W5P4 1/20 0.33
MAOA P21397 3/20 0.33
MAOB P27338 2/20 0.33
IMPDH2 P12268 1/20 0.33
MEN1 O00255 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21687623 0.92 CYP11B1 (0.37) ALDH1A1SMN1; SMN2LMNAHPGDMAPK1
SCHEMBL21688022 0.92 PTGER4 (0.34) ALDH1A1SMN1; SMN2LMNAHPGDMAPK1
SCHEMBL21688078 0.91 ALDH1A1 (0.37) ALDH1A1SMN1; SMN2LMNAHPGDMAPK1
SCHEMBL21688010 0.88 ALDH1A3 (0.35) ALDH1A1SMN1; SMN2LMNAHPGDMAPK1
SCHEMBL21688182 0.88 PGR (0.33) ALDH1A1SMN1; SMN2LMNAHPGDMAPK1
SCHEMBL21687856 0.88 CYP11B2 (0.34) ALDH1A1SMN1; SMN2LMNAHPGDMAPK1
SCHEMBL21687739 0.88 KDM4E (0.35) ALDH1A1SMN1; SMN2LMNAHPGDMAPK1
SCHEMBL21687870 0.87 SMN1; SMN2 (0.41) ALDH1A1SMN1; SMN2LMNAHPGDMAPK1
SCHEMBL28573129 0.87 KDM4E (0.43) ALDH1A1SMN1; SMN2LMNAHPGDMAPK1
SCHEMBL21688108 0.86 KDM4E (0.34) ALDH1A1SMN1; SMN2LMNAHPGDMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11201300-B2 Condensed cyclic compound and organic light-emitting device including condensed cyclic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-12-14 US disclosed
US-20200044168-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-02-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200044168-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND CRY1, CCNL2, CCNE2 ALDH1A1 616/4885SMN1; SMN2 4039/4885LMNA 1582/4885
US-11201300-B2 Condensed cyclic compound and organic light-emitting device including condensed cyclic compound CRY1, CCNL2, CCNE2 ALDH1A1 616/4885SMN1; SMN2 4039/4885LMNA 1582/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.